Sandoz - US Dermatology Business' Unit Acquisition

Sandoz - US Dermatology Business raised a round of funding on September 06, 2018. Investors include Aurobindo Pharma.

Sandoz, a Novartis company, is a provider of generic pharmaceuticals and biosimilars, driving sustainable access to healthcare. Sandoz supplies a broad range of off-patent products to patients and cus…

Articles about Sandoz - US Dermatology Business' Unit Acquisition: